Blood and Urine Biomarkers in Osteoarthritis - an Update on Cartilage Associated Type II Collagen and Aggrecan Markers

Overview

Journal Curr Opin Rheumatol

Specialty Rheumatology

Date 2021 Oct 15

PMID 34652292

Citations 20

Authors

Anne C Bay-Jensen

Ali Mobasheri

Christian S Thudium

Virginia B Kraus

Morten A Karsdal

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Osteoarthritis (OA) is a painful disease for which drug development has proven difficult. One major reason for this is the heterogeneity of the disease and the current lack of operationalized means to distinguish various disease endotypes (molecular subtypes). Biomarkers measured in blood or urine, reflecting joint tissue turnover, have been developed and tested during the last decades. In this narrative review, we provide highlights on biomarkers derived from the two most studied and abundant cartilage proteins - type II collagen and aggrecan.

Recent Findings: Multiple biomarkers assessing type II collagen degradation and formation, and aggrecan turnover have been developed. Several markers, such as uCTX-II, have been validated for their association with disease severity and prognosis, as well as pharmacodynamically used to describe the mode of action and efficacy of drugs in development. There is a great need for biomarkers for subdividing patients (i.e., endotyping) and recent scientific advances have not yet come closer to achieving this goal.

Summary: There is strong support for using biomarkers for understanding OA, reflecting degradation and formation of the joint tissues, focused on type II collagen and aggrecan. There is still a lack of in vitro diagnostics, in all contexts of use.

Citing Articles

Interconnected Pathways: Exploring Inflammation, Pain, and Cognitive Decline in Osteoarthritis.

Tarasovs M, Skuja S, Svirskis S, Sokolovska L, Vikmanis A, Lejnieks A Int J Mol Sci. 2024; 25(22).

PMID: 39595987 PMC: 11594107. DOI: 10.3390/ijms252211918.

Bioprinted High-Cell-Density Laminar Scaffolds Stimulate Extracellular Matrix Production in Osteochondral Co-Cultures.

Bowes A, Collins A, Oakley F, Gentile P, Marina Ferreira A, Dalgarno K Int J Mol Sci. 2024; 25(20).

PMID: 39456913 PMC: 11508368. DOI: 10.3390/ijms252011131.

Unveiling MRI-based structural phenotypes in temporomandibular joint osteoarthritis: implications for clinical practice and research.

Tesch R, Calcia T, De Nordenflycht D Dental Press J Orthod. 2024; 29(4):e24spe4.

PMID: 39230116 PMC: 11368237. DOI: 10.1590/2177-6709.29.4.e24spe4.

β-Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2/AMPK/PINK1/Parkin pathway.

Zhuang H, Ren X, Zhang Y, Li H, Zhou P Aging Cell. 2024; 23(11):e14294.

PMID: 39126207 PMC: 11561673. DOI: 10.1111/acel.14294.

Advances in Molecular Research on Hip Joint Impingement-A Vascular Perspective.

Huzum R, Hinganu M, Huzum B, Hinganu D Biomolecules. 2024; 14(7).

PMID: 39062498 PMC: 11275018. DOI: 10.3390/biom14070784.

References

Luo Y, Samuels J, Krasnokutsky S, Byrjalsen I, Kraus V, He Y . A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis. J Orthop Traumatol. 2021; 22(1):10. PMC: 7943687. DOI: 10.1186/s10195-021-00572-0. View

Hick A, Malaise M, Loeuille D, Conrozier T, Maugars Y, Pelousse F . Cartilage Biomarkers Coll2-1 and Coll2-1NO2 Are Associated with Knee OA MRI Features and Are Helpful in Identifying Patients at Risk of Disease Worsening. Cartilage. 2021; 13(1_suppl):1637S-1647S. PMC: 8808823. DOI: 10.1177/19476035211021892. View

Alexander Jr L, McHorse G, Huebner J, Bay-Jensen A, Karsdal M, Kraus V . A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis. Arthritis Res Ther. 2021; 23(1):226. PMC: 8407005. DOI: 10.1186/s13075-021-02610-y. View

Sandell L, Morris N, Robbins J, Goldring M . Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol. 1991; 114(6):1307-19. PMC: 2289128. DOI: 10.1083/jcb.114.6.1307. View

Cheng H, Hao B, Sun J, Yin M . C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2018; 11(4):512-520. PMC: 7488952. DOI: 10.1177/1947603518798884. View

Miller R, Ishihara S, Tran P, Golub S, Last K, Miller R . An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight. 2018; 3(6). PMC: 5926921. DOI: 10.1172/jci.insight.95704. View

Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas P, Vignon E . Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2003; 62(10):939-43. PMC: 1754328. DOI: 10.1136/ard.62.10.939. View

Karsdal M, Henriksen K, Bay-Jensen A, Molloy B, Arnold M, John M . Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials. J Clin Pharmacol. 2010; 51(4):460-71. DOI: 10.1177/0091270010372625. View

Luo Y, He Y, Reker D, Gudmann N, Henriksen K, Simonsen O . A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation. Int J Mol Sci. 2018; 19(11). PMC: 6275061. DOI: 10.3390/ijms19113485. View

10.

Manicourt D, Azria M, Mindeholm L, Thonar E, Devogelaer J . Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 2006; 54(10):3205-11. DOI: 10.1002/art.22075. View

11.

Dahlberg L, Billinghurst R, Manner P, Nelson F, Webb G, Ionescu M . Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum. 2000; 43(3):673-82. DOI: 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8. View

12.

Little C, Meeker C, Golub S, Lawlor K, Farmer P, Smith S . Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest. 2007; 117(6):1627-36. PMC: 1866253. DOI: 10.1172/JCI30765. View

13.

Billinghurst R, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C . Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997; 99(7):1534-45. PMC: 507973. DOI: 10.1172/JCI119316. View

14.

Bay-Jensen A, Thudium C, Gualillo O, Mobasheri A . Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development. Drug Discov Today. 2017; 23(2):349-358. DOI: 10.1016/j.drudis.2017.10.008. View

15.

Heinegard D, Saxne T . The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):50-6. DOI: 10.1038/nrrheum.2010.198. View

16.

Siebuhr A, He Y, Gudmann N, Gram A, Kjelgaard-Petersen C, Qvist P . Biomarkers of cartilage and surrounding joint tissue. Biomark Med. 2014; 8(5):713-31. DOI: 10.2217/bmm.13.144. View

17.

Nemirovskiy O, Dufield D, Sunyer T, Aggarwal P, Welsch D, Mathews W . Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Anal Biochem. 2006; 361(1):93-101. DOI: 10.1016/j.ab.2006.10.034. View

18.

Heinemeier K, Schjerling P, Heinemeier J, Moller M, Krogsgaard M, Grum-Schwensen T . Radiocarbon dating reveals minimal collagen turnover in both healthy and osteoarthritic human cartilage. Sci Transl Med. 2016; 8(346):346ra90. DOI: 10.1126/scitranslmed.aad8335. View

19.

Garnero P, Ayral X, Rousseau J, Christgau S, Sandell L, Dougados M . Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum. 2002; 46(10):2613-24. DOI: 10.1002/art.10576. View

20.

Bay-Jensen A, Bihlet A, Byrjalsen I, Andersen J, Riis B, Christiansen C . Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis. Sci Rep. 2021; 11(1):6583. PMC: 7985384. DOI: 10.1038/s41598-021-86064-x. View